Therapy News and Research

RSS

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Intravenous iron replacement reduces risk of recurrent hospitalization in patients with heart failure

Patients who were hospitalized with acute heart failure and had iron deficiency were less likely to return to the hospital if given intravenous iron replacement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.

15 Nov 2020

Study helps quantify racial and ethnic disparities in pediatric diabetes treatment

Type 1 diabetes (T1D) is the third most common pediatric chronic disease in the United States, and the risk of the disease has risen sharply in non-Hispanic Black (NHB) children in the last 20 years, data show.

12 Nov 2020

JNCCN: Cost-effectiveness of olaparib for metastatic pancreatic cancer

Studies have shown that utilizing a PARP inhibitor in the management of patients with metastatic pancreatic cancer who harbor BRCA 1/2 mutations is clinically beneficial.

12 Nov 2020

Convalescent plasma in COVID-19 can be effective, especially early in disease

A team of researchers in the United States have conducted an extensive literature review looking at the usage of convalescent plasma from recovered COVID-19 patients to treat those with an impaired immune system. Their study, titled “Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review,” has been released on medRxiv*, the preprint server.

12 Nov 2020

Baycrest scientists use individualized brain stimulation to treat aphasia in stroke survivors

Baycrest scientists are pioneering the use of individualized brain stimulation therapy to treat aphasia in recovering stroke patients.

12 Nov 2020

Weekly exercise linked to lower risk of Alzheimer's disease in patients with mild cognitive impairment

Exercising more than once per week is associated with a lower risk of developing Alzheimer's disease in patients with mild cognitive impairment, research published in the open access journal Alzheimer's Research and Therapy suggests.

12 Nov 2020

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Light-activated liposomes could help to deliver CRISPR gene therapy - and the method could prove safer and more direct than current methods.

12 Nov 2020

Discovering a new role for a protein that could cause breast cancer to spread to the lungs

In this interview, News-Medical speaks to Dr. Cristina Branco from Breast Cancer Now about the spread of breast cancer cells to the lungs.

12 Nov 2020

Study shows potential of new pinprick blood test for diagnosing HPV-related cancers

A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papilloma viruses has emerged.

12 Nov 2020

Researchers assess the risk of proton therapy for children with brain tumors

Adelaide is poised to open Australia's first proton therapy center in 2025, with children and young adults expected to be the main beneficiaries of more effective cancer treatment with fewer side effects.

12 Nov 2020

$Reduced lead exposure may explain the declining rates of hip fracture$

Reduced lead exposure may explain the declining rates of hip fracture

Hip fractures are one of the leading causes of hospitalization among older adults and are a strong predictor of mortality.

12 Nov 2020

Researchers identify acrylamides that inhibit SARS-CoV-2 main protease

A new study in the preprint server bioRxiv published in November 2020 describes the discovery of acrylamide fragments that can effectively disable key enzymes in both the hand, foot and mouth virus and SARS-CoV-2 virus.

11 Nov 2020

Men and women may require different brain tumor therapy, study finds

The current study shows that the sex differences in the tumor phenotype vary with the effect of the enhancer regulatory molecule bound to Brd4 on the course of stem cell-like differentiation in male and female GBM cells. Inhibition of Brd4 by genetic and pharmacological factors also varies in males and females, both in vivo and in vitro.

11 Nov 2020

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting & Pre-Conference Programs.

11 Nov 2020

Researchers find a better way to block asthma triggers

Every day, ten Americans die from asthma. While quick-acting inhalers and medications can reduce inflammation during an asthma attack, people with asthma have few tools to prevent the next attack from coming.

11 Nov 2020

Pitt neuroscientists uncover additional complexities behind sensation of pain from light touch

Researchers from the Pittsburgh Center for Pain Research at the University of Pittsburgh School of Medicine announced today in the journal Neuron that they've uncovered additional complexities behind mechanical allodynia--the sensation of pain from innocuous stimuli, such as light touch.

11 Nov 2020

Researchers uncover potential genetic target for treating endometriosis

Michigan State University researchers have identified a potential genetic target for treating an especially painful and invasive form of endometriosis.

11 Nov 2020

Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds

Researchers have found that nafamostat mesylate, when injected in the nasal cavity of Syrian hamsters, can decrease initial SARS-CoV-2 viral loads in their nose. However, this effect was temporary and further testing is required to determine clinically significant effects. The research group's findings are available on the preprint server bioRxiv*.

11 Nov 2020

Therapy News and Research

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Intravenous iron replacement reduces risk of recurrent hospitalization in patients with heart failure

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Study helps quantify racial and ethnic disparities in pediatric diabetes treatment

JNCCN: Cost-effectiveness of olaparib for metastatic pancreatic cancer

Convalescent plasma in COVID-19 can be effective, especially early in disease

Baycrest scientists use individualized brain stimulation to treat aphasia in stroke survivors

Weekly exercise linked to lower risk of Alzheimer's disease in patients with mild cognitive impairment

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Discovering a new role for a protein that could cause breast cancer to spread to the lungs

Study shows potential of new pinprick blood test for diagnosing HPV-related cancers

Researchers assess the risk of proton therapy for children with brain tumors

Reduced lead exposure may explain the declining rates of hip fracture

Researchers identify acrylamides that inhibit SARS-CoV-2 main protease

Men and women may require different brain tumor therapy, study finds

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

Researchers find a better way to block asthma triggers

Pitt neuroscientists uncover additional complexities behind sensation of pain from light touch

Researchers uncover potential genetic target for treating endometriosis

Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News